Blog

OncoSec to Present at Upcoming Healthcare and Investor Conferences

CEO Punit Dhillon Will Present at BIOX, Cancer Immunotherapy and IN3 Device Conferences and Participate at Burrill and Cowen Conferences

SAN DIEGO – September 20, 2012 — OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon, President and CEO, will present at the following healthcare and investor conferences in upcoming weeks:

– Noble Financial BioXposition (BIOX), University of Connecticut, Stamford Campus, Stamford, CT, September 24 at 4:00 PM ET

– MD Becker Third Annual “Cancer Immunotherapy: A Long Awaited Reality” Conference, New York Academy of Medicine, New York, NY, October 4 at 9:15 AM ET

– Investment in Innovation (IN3) Medical Device 360° Summit, Intercontinental Mark Hopkins, San Francisco, CA, October 16 at 10:30 AM PT

In addition, Mr. Dhillon will attend the exclusive Burrill & Company Biotech Meeting in Laguna Beach, CA on October 7-9 and the Cowen Group 15th Annual Therapeutics Conference in New York, NY on October 10.

Following the Noble Financial and MD Becker events, a video webcast of the presentations can be viewed on OncoSec’s website at: http://oncosec.com/index.php/press-media/events-media/